CHRONIC PARVOVIRUS B19 INFECTION AND SYSTEMIC NECROTIZING VASCULITIS - OPPORTUNISTIC INFECTION OR ETIOLOGIC AGENT

被引:276
作者
FINKEL, TH
TOROK, TJ
FERGUSON, PJ
DURIGON, EL
ZAKI, SR
LEUNG, DYM
HARBECK, RJ
GELFAND, EW
SAULSBURY, FT
HOLLISTER, JR
ANDERSON, LJ
机构
[1] CTR DIS CONTROL & PREVENT,NATL CTR INFECT DIS,DIV VIRAL & RICKETTSIAL DIS,ATLANTA,GA
[2] UNIV VIRGINIA,HLTH SCI CTR,DEPT PEDIAT,CHARLOTTESVILLE,VA
[3] UNIV SAO PAULO,INST BIOMED SCI,SAO PAULO,BRAZIL
[4] UNIV COLORADO,CHILDRENS HOSP,HLTH SCI CTR,DENVER,CO 80218
关键词
D O I
10.1016/S0140-6736(94)92152-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We describe three patients who had infection with human parvovirus B19 in association with new-onset systemic necrotising vasculitis syndromes, two with features of polyarteritis nodosa and one with features of Wegener's granulomatosis. Chronic B19 infection, lasting 5 months to more than 3 years, was shown by enzyme immunoassay for IgG and IgM antibodies to B19 and polymerase chain reaction for B19 DNA in serum and tissue samples. The patients had atypical serological responses to the B19 infection, although none had a recognisable immunodeficiency disorder. Treatment with corticosteroids and cyclophosphamide did not control vasculitis. Intravenous immunoglobulin (IVIG) therapy led to rapid improvement of the systemic vascultis manifestations, clearing of the chronic parvovirus infection, and long-term remission. These observations suggest an aetiological relation between parvovirus B19 infection and systemic necrotising vasculitis in these patients and indicate a potentially curative role for IVIG in such disorders.
引用
收藏
页码:1255 / 1258
页数:4
相关论文
共 27 条
  • [1] HUMAN PARVOVIRUS-B19 AND PREGNANCY
    ANDERSON, LJ
    HURWITZ, ES
    [J]. CLINICS IN PERINATOLOGY, 1988, 15 (02) : 273 - 286
  • [2] EXPERIMENTAL PARVOVIRAL INFECTION IN HUMANS
    ANDERSON, MJ
    HIGGINS, PG
    DAVIS, LR
    WILLMAN, JS
    JONES, SE
    KIDD, IM
    PATTISON, JR
    TYRRELL, DAJ
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1985, 152 (02) : 257 - 265
  • [3] ERYTHROCYTE-P ANTIGEN - CELLULAR RECEPTOR FOR B19 PARVOVIRUS
    BROWN, KE
    ANDERSON, SM
    YOUNG, NS
    [J]. SCIENCE, 1993, 262 (5130) : 114 - 117
  • [4] POLYARTERITIS-NODOSA AND PARVOVIRUS-B19 INFECTION
    CORMAN, LC
    DOLSON, DJ
    [J]. LANCET, 1992, 339 (8791) : 491 - 491
  • [5] CORMAN LC, 1992, ARTHRITIS RHEUM, V35, pS165
  • [6] IDENTIFICATION OF THE MAJOR STRUCTURAL AND NONSTRUCTURAL PROTEINS ENCODED BY HUMAN PARVOVIRUS-B19 AND MAPPING OF THEIR GENES BY PROKARYOTIC EXPRESSION OF ISOLATED GENOMIC FRAGMENTS
    COTMORE, SF
    MCKIE, VC
    ANDERSON, LJ
    ASTELL, CR
    TATTERSALL, P
    [J]. JOURNAL OF VIROLOGY, 1986, 60 (02) : 548 - 557
  • [7] MULTIPLE PRIMER PAIRS FOR POLYMERASE CHAIN-REACTION (PCR) AMPLIFICATION OF HUMAN PARVOVIRUS-B19 DNA
    DURIGON, EL
    ERDMAN, DD
    GARY, GW
    PALLANSCH, MA
    TOROK, TJ
    ANDERSON, LJ
    [J]. JOURNAL OF VIROLOGICAL METHODS, 1993, 44 (2-3) : 155 - 165
  • [8] MASSIVE COVERT INFECTION OF HELPER T-LYMPHOCYTES AND MACROPHAGES BY HIV DURING THE INCUBATION PERIOD OF AIDS
    EMBRETSON, J
    ZUPANCIC, M
    RIBAS, JL
    BURKE, A
    RACZ, P
    TENNERRACZ, K
    HAASE, AT
    [J]. NATURE, 1993, 362 (6418) : 359 - 362
  • [9] HUMAN PARVOVIRUS B19 SPECIFIC IGG, IGA, AND IGM ANTIBODIES AND DNA IN SERUM SPECIMENS FROM PERSONS WITH ERYTHEMA-INFECTIOSUM
    ERDMAN, DD
    USHER, MJ
    TSOU, C
    CAUL, EO
    GARY, GW
    KAJIGAYA, S
    YOUNG, NS
    ANDERSON, LJ
    [J]. JOURNAL OF MEDICAL VIROLOGY, 1991, 35 (02) : 110 - 115
  • [10] CHRONIC PARVOVIRUS INFECTION IN A PRESUMABLY IMMUNOLOGICALLY HEALTHY WOMAN
    FADEN, H
    GARY, GW
    ANDERSON, LJ
    [J]. CLINICAL INFECTIOUS DISEASES, 1992, 15 (04) : 595 - 597